Impact of upper and lower gastrointestinal blood loss on healthcare utilization and costs: A systematic review

Journal of Medical Economics

Volumn 14, Issue 3, 2011, Pages 279-287

  Parker, Donna R ^a,b,c   Luo, Xuemei ^d   Jalbert, Jessica J ^e   Assaf, Annlouise R ^b  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d PFIZER INC   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Blood loss; Costs; Gastrointestinal; Healthcare utilization

Indexed keywords

CANADA; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; INTESTINAL BLEEDING; LENGTH OF STAY; LOWER GASTROINTESTINAL BLEEDING; MEDICAL RECORD REVIEW; MEDLINE; NETHERLANDS; PEER REVIEW; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; UNITED STATES; UPPER GASTROINTESTINAL BLEEDING;

ADOLESCENT; ADULT; DEVELOPED COUNTRIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH SERVICES; HUMANS; MALE; YOUNG ADULT;

EID: 79956107773     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2011.571328     Document Type: Review

References (30)

1. Velayos FS, Williamson A, Sousa KH, et al. Early predictors of severe lower gastrointestinal bleeding and adverse outcomes: a prospective study. Clin Gastroenterol Hepatol 2004;2:485-90 (Pubitemid 38698364)
2. Quirk DM, Barry MJ, Aserkoff B, et al. Physician specialty and variations in the cost of treating patients with acute upper gastrointestinal bleeding. Gastroenterology 1997;113:1443-8 (Pubitemid 27461229)
3. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995;90:206-10
4. Cagir B. Lower GI bleeding, surgical treatment. http://emedicine. medscape.com/article/195246-overview. Accessed 11/12/2010
5. Cryer BL, Wilcox CM, Henk HJ, et al. The economics of upper gastrointestinal bleeding in a US-managed care setting: a retrospective claims-based analysis. J Med Econ 2010;3:70-7
6. Wilcox C M, Cryer BL, Henk HJ, et al. Mortality associated with gastrointestinal bleeding events: comparing short-term clinical outcomes of patients hospitalized for upper GI bleeding and acute myocardial infarction in a US managed care setting. Clin Exp Gastroenterol 2009;2: 21-30
7. Wilcox CM, Clark WS. Causes and outcome of upper and lower gastrointestinal bleeding: the Grady Hospital experience. South Med J 1999;92:44-50 (Pubitemid 29048816)
8. Yavorski RT, Wong RK, Maydonovitch C, et al. Analysis of 3,294 causes of upper gastrointestinal bleeding military medical facilities. Am J Gastroenterol 1995;90:568-73
9. Prakash C, Zucherman GR. Acute small bowel bleeding: a distinct entity with significantly different economic implications compared with GI bleeding from other locations. Gastrointest Endosc 2003;58:330-5 (Pubitemid 38220229)
10. Zuckerman GR, Prakash C. Acute lower intestinal bleeding. Part I: clinical presentation and diagnosis. Gastrointest Endosc 1998;48:606-16 (Pubitemid 28566545)
11. Zuckerman GR, Prakash C. Acute lower intestinal bleeding. Part II: Etiology, therapy, and outcomes. Gastrointest Endosc 1999;49:228-38 (Pubitemid 29111318)
12. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-27 (Pubitemid 24275746)
13. Champion G, Feng PH, Azuma T, et al. NSAID-induced gastrointestinal damage: epidemiology, risk and prevention with an evaluation of the role of misoprostol: an Asian-Pacific perspective and consensus. Drugs 1997; 53:6-19 (Pubitemid 27042230)
14. Singh G, Ramey DR, Morfeld D, et al. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study. Arch Intern Med 1996;156:1530-6
15. Dai C, Stafford RS, Alexander GC. National trends in cyclooxygenase-2 inhibitor use since market release: non-selective diffusion of a selectively costeffective innovation. Arch Intern Med 2005;165:171-7
16. Graham DY, Chan FK. NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology 2008;134:1240-6 (Pubitemid 351451996)
17. Schünemann HJ, Oxman AD, Vist GE, et al. Interpreting results and drawing conclusions. In: Higgins JPT, Green S (eds), Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0, Chapter 12 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook. org
18. Atkins D, Best D, Briss PA, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations BMJ 2004;328:1490
19. Richter JM, Wang TC, Fawaz K, et al. Practice patterns and costs of hospitalization for upper gastrointestinal hemorrhage. J Clin Gastroenterol 1991;13:268-73
20. Marshall JK, Collins SM, Gafni A. Prediction of resource utilization and case cost for acute nonvariceal upper gastrointestinal hemorrhage at a Canadian Community Hospital. Am J Gastroenterol 1999;94:1841-6 (Pubitemid 29315896)
21. Marshall J, Collins S, Gafini A. Demographic predictors of resource utilization for bleeding peptic ulcer disease: The Ontario GI Bleed Study. J Clin Gastroenterol 1999;29:165-70 (Pubitemid 29404465)
22. Comay D, Marshall JK. Resource utilization for acute lower gastrointestinal hemorrhage: The Ontario GI Bleed Study. Can J Gastroenterol 2002;16:677-82 (Pubitemid 35402220)
23. De Leest HTJI, Van Dieten HEM, Van Tulder MW, et al. Costs of treating bleeding and perforated peptic ulcers in the Netherlands. J Rheumatol 2004;31:788-91 (Pubitemid 38451270)
24. Whelan CT, Chen C, Kaboli P, et al. Upper versus lower gastrointestinal bleeding: a direct comparison of clinical presentation, outcomes, and resource utilization. J Hosp Med 2010;5:141-7
25. Bhatt DL, Scheiman J, Abraham NS, et al. American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008;118:1894-909
26. Graham DY, Chan FK. NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology 2008;134:1240-6 (Pubitemid 351451996)
27. Bjarnason I, Hayllar J, MacPherson AJ, et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832-47 (Pubitemid 23235480)
28. American College of Rheumatology ad hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum 2008;59:1058-73
29. Schnitzer TJ. Proceedings from the Symposium "The Evolution of Anti-Inflammatory Treatments in Arthritis: Current and Future Perspectives" Update of ACR Guidelines for Osteoarthritis: Role of the Coxibs. J Pain Symptom Manage 2002;23(4S):S24-30
30. Morrison A, Moulton K, Clark M, et al. English language restriction when conducting a systematic review-based-meta-analysis: systematic review of published studies. Canadian Agency for Drugs and Technologies in Health, 2009